로딩 중…
지수 로딩 중…
JW LIFESCIENCE CORPORATION
234080· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩11,360-0.35%
2026-06-19
Price Chart
JW LIFESCIENCE CORPORATION-6.73%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 179.88B KRW |
| Revenue | 252.72B KRW |
| Net Income | 7.03B KRW |
| Total Assets | 313.55B KRW |
| Net Assets | 218.75B KRW |
| Employees | 328 |
| Value | |
| P/E | 25.58x |
| P/B | 0.82x |
| PEG | 2.70x |
| P/S | 0.71x |
| EV/EBITDA | 27.44x |
| FCF Yield | 15.56% |
| Profitability | |
| ROE | 3.21% |
| ROA | 2.24% |
| Op. Margin | 13.20% |
| Revenue Growth | -7.44% |
| Earnings Growth | 9.49% |
| Financial Health | |
| Debt Ratio | 43.34% |
| Total Debt | 40.34B KRW |
| FCF | 27.98B KRW |
| Cash | 8.86B KRW |
| Current Ratio | 1.09x |
| Net Debt/EBITDA | 4.09x |
| Dividend | |
| Div. Yield | 4.83% |
| Div. Growth | 10.00% |
| Performance | |
| 1Y Return | -6.73% |
| 1M Return | -2.82% |
| From 52W High | -27.09% |
| 1Y MDD | -30.77% |
| Trading | |
| Volume | 59,398 shares |
| Foreign Own. | 13.25% |
| Per Share | |
| EPS | 1,843 KRW |
| BPS | 14,127 KRW |
Company Info
Established in 1994, this company produces and sells professional pharmaceutical infusions, including 3-Chamber nutritional infusions, which are manufactured by only a few companies. It has signed licensing-out and export contracts with global infusion manufacturer Baxter Corporation, becoming the first in Asia to obtain EU-GMP certification for its TPN production facility, recognizing its world-class production infrastructure. The HP Research Center is pursuing global growth through the development of non-PVC materials and the launch of TPN products, leveraging infusion-related technologies. JW Life Science is headquartered in Dangjin, Chungcheongnam-do.